drugset / Trial / NCT00963937
Study to Evaluate the Efficacy and Safety of Oral Sumatriptan for the Acute Treatment of Migraine in Children and Adolescents
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of a range of doses of oral sumatriptan for the acute treatment of migraine in children ages 10 to 17.
Timeline
- Start
- 2009-09-28
- Primary completion
- 2010-12-01
- Completion
- 2010-12-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Sumatriptan | Unknown | 25 mg | Oral |
| Comparator | Sumatriptan | Unknown | 50 mg | Oral |